See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / Income Statements

Income Statements

08:02am, Tuesday, May 13, 2025

Iterum Therapeutics Reports Q1 2025 Loss Improvement Amid Ongoing Financial Challenges

Iterum Therapeutics plc (NASDAQ: ITRM) has recently released its quarterly financial report for the period ended March 31, 2025. Below are the key points and statistics concerning its income statement, as well as notable positive and negative aspects impacting the company. Positive Aspects: Net ...

08:02am, Tuesday, May 13, 2025

Y-mAbs Therapeutics Implements Strategic Changes Amidst Financial Challenges and Revenue Growth

08:01am, Tuesday, May 13, 2025

Cornerstone Building Brands Reports Increased Sales Amid Rising Costs and Growing Debt Challenges

08:01am, Tuesday, May 13, 2025

Achieve Life Sciences Faces Financial Struggles Amid Promising Clinical Trial Progress

08:01am, Tuesday, May 13, 2025

XOMA Reports Massive Revenue Growth and Return to Profitability in Q1 2025

08:00am, Tuesday, May 13, 2025

Mereo BioPharma Faces Increased Losses in Q1 2025 Amidst R&D Developments and Cash Management Challenges

07:02am, Tuesday, May 13, 2025

Energy Focus, Inc. Reports Improved Profitability Amid Revenue Decline and Customer Risks in Q1 2025

07:02am, Tuesday, May 13, 2025

Regis Corporation Reports Mixed Financial Results Amid Strategic Acquisition of Alline Salon Group

07:02am, Tuesday, May 13, 2025

Peraso Inc. Reports Strong Q1 2025 Growth Amid Challenges and Ongoing Restructuring Efforts

07:01am, Tuesday, May 13, 2025

22nd Century Group Reports Decrease in Revenues but Improves Operational Efficiency in Q1 2025

07:01am, Tuesday, May 13, 2025

AsiaFIN Holdings Reports Increased Revenue but Faces Deepening Losses and Liquidity Concerns

A

07:00am, Tuesday, May 13, 2025

Leap Therapeutics Reports Mixed Q1 2025 Results with Promising Cancer Trial Data Amid Financial Concerns

06:03pm, Monday, May 12, 2025

Ascend Wellness Reports Q1 2025: Revenue and Losses Rise Amidst Cost Management Improvements

06:03pm, Monday, May 12, 2025

Bally's Corporation Sees Financial Turnaround Post-Merger with Queen Casino, Eyes Future Growth

06:02pm, Monday, May 12, 2025

Hertz Reports Q1 2025 Results: Revenue Declines Amid Improved Operational Efficiency and EBITDA

06:02pm, Monday, May 12, 2025

InMed Pharmaceuticals Reports Sales Growth Amid Rising Losses and Funding Concerns

06:01pm, Monday, May 12, 2025

Investors Title Company Reports Q1 2025 Financial Results Amid Mixed Performance Signals

06:01pm, Monday, May 12, 2025

MicroVision Faces Challenges with Declining Revenue and High Net Loss Amid Strategic Shift to Efficiency

06:00pm, Monday, May 12, 2025

Scienture Holdings Reports Revenue Growth but Faces Financial Challenges in Q1 2025

06:00pm, Monday, May 12, 2025

Mineralys Therapeutics Faces Challenges with Increased Losses Amid Promising Drug Development Progress

M

05:15pm, Monday, May 12, 2025

NET Power Reports $373.6M Loss in Q1 2025 Amid High Expenses and Goodwill Impairment

N

05:15pm, Monday, May 12, 2025

Green Dot Reports Strong Q1 2025 Earnings with 442.6% Net Income Surge Amid Operational Challenges

05:15pm, Monday, May 12, 2025

Fuel Tech Reports Mixed Q1 2025 Results with Revenue Growth but Net Loss Amid Operational Challenges

05:14pm, Monday, May 12, 2025

Neumora Therapeutics Faces Significant Losses Amid Promising Clinical Trials and Strategic Collaborations

N

05:14pm, Monday, May 12, 2025

Perspective Therapeutics Reports Rising Losses Amid Growing R&D Investment and Grant Revenue Boost

05:13pm, Monday, May 12, 2025

Vital Energy Reports Q1 2025: Revenue Grows 6% Despite Wider Net Loss Due to Impairments

05:13pm, Monday, May 12, 2025

Tonix Pharmaceuticals Reports Q1 2025 Results: Revenue Down, Cash Position Strengthened Despite Losses

05:13pm, Monday, May 12, 2025

Ironwood Pharmaceuticals Faces Significant Challenges as Q1 2025 Financials Report Deep Losses

05:12pm, Monday, May 12, 2025

CompoSecure Reports Mixed Financial Results Amid Spin-off Transition and Operational Challenges

05:12pm, Monday, May 12, 2025

ZyVersa Therapeutics Faces Financial Challenges Amid Improved Q1 Losses and Ongoing Liquidity Issues

Z

05:11pm, Monday, May 12, 2025

Xerox Reports Q1 2025 Results: Mixed Performance Amid Restructuring and ITsavvy Acquisition Impact

05:11pm, Monday, May 12, 2025

Seaport Entertainment Group Reports Strong Revenue Growth Amid Ongoing Financial Challenges

S

05:10pm, Monday, May 12, 2025

Ampco-Pittsburgh Reports Q1 2025 Gain in Net Income Despite Declining Sales and Rising Costs

05:10pm, Monday, May 12, 2025

NuScale Power Reports Strong Revenue Growth Amid Ongoing Losses in Q1 2025 Earnings Snapshot

S

05:09pm, Monday, May 12, 2025

Ultralife Corporation Reports Q1 2025 Earnings: Revenue Growth Amid Rising Costs and Margin Pressures

U

05:09pm, Monday, May 12, 2025

Babcock & Wilcox Reports Q1 2025 Results: Revenue Rises Amid Increased Losses and Debt Challenges

05:08pm, Monday, May 12, 2025

Magnachip Reports Q1 2025 Results, Shifts Focus to Power Solutions Amid Strategic Transition

05:08pm, Monday, May 12, 2025

Xenon Pharmaceuticals Reports Q1 2025 Loss Amid Strong R&D Investment and Collaboration Revenue Growth

05:08pm, Monday, May 12, 2025

Atea Pharmaceuticals Reports Major Expense Cuts and Improved Financials Amid Ongoing Challenges

A

05:07pm, Monday, May 12, 2025

Topgolf Callaway Reports Q1 2025 Losses Amid Revenue Decline and Strategic Business Changes

«
1
2
...
71
72
73
74
75
76
77
...
111
112
»